Mallinckrodt to Present at Cowen's 43rd Annual Health Care Conference
Individuals who cannot attend the meeting in person can find webcast information at: https://wsw.com/webcast/cowen132/mnk/1849260. A replay will also be available following the meeting.
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The Company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Mallinckrodt uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the
Global Corporate Controller & Chief Investor Relations Officer
Vice President, Investor Relations
Michael Freitag / Aaron Palash / Aura Reinhard
Joele Frank, Wilkinson Brimmer Katcher
Mallinckrodt, the "M" brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. © 2023 02/23.
View original content to download multimedia:https://www.prnewswire.com/news-releases/mallinckrodt-to-present-at-cowens-43rd-annual-health-care-conference-301748832.html